drugset / Trial / NCT01575782

Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer

NCT01575782

Phase 1 Terminated 5 enrolled Maastricht Radiation Oncology
NaSingle-groupOpen-labelTreatment

Summary

Chloroquine can make tumor cells less resistant to chemo/radiotherapy. In this trial chloroquine is given during radiotherapy. The dose is increased in cohorts of at least 3 patients.

Timeline

Start
2014-05
Primary completion
2017-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule